CVHNLC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CVHNLC, covering 2025-07-18 to 2025-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) [Phase 1]